Leyden Laboratories
Develops broadly protective antibody-based nasal sprays to prevent infection by influenza and other respiratory viruses
€40MSeries B
Role not disclosedLoading investors…
Loading investors…
Activity from announced rounds
Develops broadly protective antibody-based nasal sprays to prevent infection by influenza and other respiratory viruses
Develops microbiome-based live biotherapeutics for cancer patients who do not respond to immunotherapy
Develops AI-driven crop improvement solutions for climate-resilient crops
Pitching Gates Foundation? Send the deck from a free RoundOS data room and see which pages they read.
Create a free room